Antipodes Partners’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164M Buy
1,773,357
+50,765
+3% +$4.72M 3.01% 8
2026
Q1
$167M Buy
1,722,592
+121,007
+8% +$11.1M 3.22% 6
2025
Q4
$141M Sell
1,601,585
-76,366
-5% -$6.95M 2.97% 9
2025
Q3
$151M Buy
+1,677,951
New +$136M 3.39% 8

Other funds holding SRE

Antipodes Partners's SRE Position: Q2 2026 in Review

Antipodes Partners increased its Sempra (SRE) stake by 2.9% in Q2 2026, buying an estimated $4.72M and bringing the position to 1,773,357 shares worth $164M. The position accounts for 3.01% of the portfolio, ranked #8.

Antipodes Partners first reported a position in SRE in Q3 2025 and has held it in 4 quarters since. The position peaked at $167M in Q1 2026. 771 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • Antipodes Partners held 1,773,357 shares of Sempra worth $164M as of Q2 2026.
  • Antipodes Partners bought 50,765 Sempra shares in Q2 2026, an estimated $4.72M.
  • Sempra made up 3.01% of Antipodes Partners's portfolio in Q2 2026, its #8 holding.
  • Antipodes Partners first reported a position in Sempra in Q3 2025 and has held it in 4 quarters since.
  • Antipodes Partners's Sempra position peaked at $167M in Q1 2026.
  • 771 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.